Cerebrospinal fluid (CSF) candidate markers (CHI3L1, parvalbumin) and synaptic proteins (SNAP-25, neurogranin, β-synuclein) may help identifying patients at higher risk of cognitive decline. This evidence concerns the gene SNCB and Mental deterioration.